Although we observed an increase in the DP1 ligand PGD2 in both the brain and peripheral blood of aged mice, the clinical relevance of this finding to age‐related cognitive decline and neurodegenerative diseases awaits further investigation in a large cohort of aging individuals. Here, PTGDS is linked to neurodegenerative disease.